Equity criteria | Efficiency criteria | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number of respondents | The technology is intended for patients suffering from a serious disease (life expectancy is less than 2 healthy years): Yes | The Technology is intended to treat a disease common among children: Yes | The technology is intended to treat a disease common among the elderly: Yes | Funding the technology is required so that the poor can use it: Yes | Cost per Quality Adjusted Life Year: Less than the GNP per capita | The Number of patients requiring the technology: more than 100,000 | Individual Benefit: addition of more than 5 healthy years | Efficiency Weight | Equity Weight | Total | |
Physicians | 25 | 11 | 16 | 9 | 20 | 12 | 14 | 18 | 44 | 56 | 100 |
Non-physicians | 15 | 8 | 15 | 9 | 19 | 13 | 18 | 18 | 49 | 51 | 100 |
Ever served on Basket Committee | 11 | 9 | 15 | 9 | 16 | 16 | 16 | 20 | 51 | 49 | 100 |
Never did | 29 | 10 | 16 | 9 | 21 | 11 | 16 | 17 | 44 | 56 | 100 |
Respondents answering the demographic questionnaire | 40 | 10 | 16 | 9 | 20 | 12 | 16 | 18 | 46 | 54 | 100 |
Respondents not answering the demographic questionnaire | 25 | 13 | 11 | 12 | 17 | 12 | 13 | 21 | 47 | 53 | 100 |
Total | 65 | 11 | 14 | 10 | 19 | 12 | 15 | 19 | 46 | 54 | 100 |